Washington: An international consortium carried out the largest-ever genetic study of cholesterol and other blood lipids and identified 21 new gene variants associated with risks of heart disease and metabolic disorders.The findings expand the list of potential targets for drugs and other treatments for lipid-related cardiovascular disease, a leading global cause of death and disability.The International IBC Lipid Genetics Consortium used the Cardiochip, a gene analysis tool invented by Brendan J. Keating, Ph.D., a scientist at the Center for Applied Genomics at The Children’s Hospital of Philadelphia.Since its creation in 2006, researchers have used the Cardiochip to pinpoint gene variants in dozens of studies. The device contains approximately 50,000 DNA markers across 2000 genes implicated in cardiovascular disease.Keating and Fotios Drenos, Ph.D., of University College London, are senior authors of the current study.
Will write my own book to tell the truth: Sonia
India-US ties at turning point: Sushma Swaraj
Hrithik upset with Rs 400 cr alimony rumours
Eating chicken could make you immune to antibiotics